DDX55 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.759600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.673600E-01
Normal-vs-Stage2
4.577600E-01
Normal-vs-Stage3
1.656580E-01
Normal-vs-Stage4
5.793800E-01
Stage1-vs-Stage2
6.614200E-02
Stage1-vs-Stage3
1.223600E-01
Stage1-vs-Stage4
7.377600E-01
Stage2-vs-Stage3
1.868820E-01
Stage2-vs-Stage4
3.297000E-01
Stage3-vs-Stage4
4.905600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.031200E-01
Normal-vs-AfricanAmerican
1.135200E-01
Normal-vs-Asian
3.511000E-01
Caucasian-vs-AfricanAmerican
1.082440E-01
Caucasian-vs-Asian
1.120580E-01
AfricanAmerican-vs-Asian
6.419000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.856400E-01
Normal-vs-Female
1.119360E-01
Male-vs-Female
7.349000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.230600E-01
Normal-vs-Age(41-60Yrs)
5.117000E-01
Normal-vs-Age(61-80Yrs)
8.384100E-02
Normal-vs-Age(81-100Yrs)
4.881400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.704200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.415430E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.425400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.742000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.616000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.905600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.093600E-01
Normal-vs-Daily Drinker
4.661200E-01
Normal-vs-Weekly Drinker
2.051000E-01
Normal-vs-Occasional Drinker
5.076200E-01
Normal-vs-Social Drinker
5.649000E-01
Non Drinker-vs-Daily Drinker
8.536200E-01
Non Drinker-vs-Weekly Drinker
9.469600E-01
Non Drinker-vs-Occasional Drinker
8.541200E-01
Non Drinker-vs-Social Drinker
6.055600E-01
Daily Drinker-vs-Weekly Drinker
9.223800E-01
Daily Drinker-vs-Occasional Drinker
6.645600E-01
Daily Drinker-vs-Social Drinker
3.980600E-01
Weekly Drinker-vs-Occasional Drinker
8.062000E-01
Weekly Drinker-vs-Social Drinker
5.627600E-01
Occasional Drinker-vs-Social Drinker
6.506200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.873600E-01
Normal-vs-Grade 2
1.593610E-01
Normal-vs-Grade 3
1.384610E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.834600E-01
Grade 1-vs-Grade 3
7.030800E-01
Grade 1-vs-Grade 4
3.873600E-01
Grade 2-vs-Grade 3
1.362420E-01
Grade 2-vs-Grade 4
1.593610E-01
Grade 3-vs-Grade 4
1.384610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.737700E-02
Normal-vs-NonDiabetic
4.881400E-01
Diabetic-vs-NonDiabetic
5.108600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.601000E-01
Normal-vs-NoPancreatitis
4.625400E-01
Pancreatitis-vs-NoPancreatitis
9.423000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.840030E-01
Normal-vs-N1
4.572600E-01
N0-vs-N1
4.387600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.073400E-01
Normal-vs-TP53-NonMutant
6.013000E-01
TP53-Mutant-vs-TP53-NonMutant
9.422400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
